Utama › Penyakit Hati › Utah
Kajian klinikal Penyakit Hati di Utah
6 kajian untuk Penyakit Hati sedang mencari peserta di lokasi di Utah.
Bandar di Utah
Teks kajian rasmi (Bahasa Inggeris)
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Ogden
Mengambil pesertaFasa 3
Umur 18 hingga 80 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Sandy City
- 89bio Clinical Study Site, West Jordan
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 3 Sep 2026 · NCT06419374Primary Sclerosing Cholangitis in Children
- The University of Utah, Salt Lake City
Mengambil pesertaKajian pemerhatian
Umur 2 hingga 25 · Semua jantina · Dikemas kini 14 Jul 2026 · NCT04181138A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Intermountain Health, Salt Lake City
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Dis 2025 · NCT06619561Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
- University of Utah Health, Salt Lake City
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 80 · Semua jantina · Dikemas kini 20 Okt 2025 · NCT04613921Long-Term SafEty and Clinical Outcomes of LivmArli in Patients in the United States (LEAP-US)
- University of Utah, Division of Pediatric Gastroenterology, Hepatology and Nutrition, Salt Lake City
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 25 Mei 2025 · NCT06193928Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.